Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
High grade lymphoma, Non-Hodgkin lymphoma (NHL)
Closed
Phase 2
This trial is looking at drug called mogamulizumab (also known as KW-0761) for that has got worse or come back after other treatment.
Recruitment start: 4 July 2012
Recruitment end: 10 January 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor John Radford
Kyowa Hakko Kirin Pharma
Inc
Last reviewed: 29 Jan 2014
CRUK internal database number: 9840